Kishor G. Bhatia - 18 Dec 2025 Form 4 Insider Report for Lantern Pharma Inc. (LTRN)

Reporting relationship: Chief Scientific Officer
Issuer ticker: LTRN
Reported as of: 18 Dec 2025
Net transaction value: $0
SEC form: 4
Accepted by SEC: 22 Dec 2025, 16:05:24 UTC
Prior SEC filing: 23 Sep 2025
Source filing: View source filing
Reporting owner signature: /s/ Kishor G. Bhatia

Key filing fact

Kishor G. Bhatia filed Form 4 for Lantern Pharma Inc. (LTRN) on 22 Dec 2025.

Key facts

This page summarizes Kishor G. Bhatia's Form 4 filing for Lantern Pharma Inc. (LTRN).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 22 Dec 2025, 16:05.

Change

Previous filing in this sequence was filed on 23 Sep 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001812638 Primary reporting owner

Bhatia Kishor G.

Relationship: Chief Scientific Officer
Address: 1920 MCKINNEY AVENUE, 7TH FLOOR, DALLAS
Signature: /s/ Kishor G. Bhatia
Signature date: 22 Dec 2025

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LTRN transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +10,000
Change %
Price: $0.000000
Shares after: 10,000
Date: 18 Dec 2025
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 10,000
Exercise price: $3.24
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The Options are granted under the Lantern Pharma Inc. Amended and Restated 2018 Stock Incentive Plan. The Options shall vest and first become exercisable in equal monthly increments over a 24-month period commencing January 18, 2026.